Singapore markets close in 5 hours 28 minutes

Cannara Biotech Inc. (LOVFF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.5932-0.0368 (-5.84%)
At close: 11:32AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 52.79M
Enterprise value 86.75M
Trailing P/E 11.55
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.00
Price/book (mrq)0.92
Enterprise value/revenue 1.62
Enterprise value/EBITDA 7.39

Trading information

Stock price history

Beta (5Y monthly) 1.17
52-week change 3-6.95%
S&P500 52-week change 327.84%
52-week high 30.8398
52-week low 30.4995
50-day moving average 30.6315
200-day moving average 30.6771

Share statistics

Avg vol (3-month) 31.76k
Avg vol (10-day) 33.32k
Shares outstanding 590.02M
Implied shares outstanding 690.22M
Float 844.23M
% held by insiders 149.42%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 313 Feb 2023

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 31 Aug 2023
Most-recent quarter (mrq)29 Feb 2024

Profitability

Profit margin 8.49%
Operating margin (ttm)-10.08%

Management effectiveness

Return on assets (ttm)5.25%
Return on equity (ttm)8.23%

Income statement

Revenue (ttm)73.26M
Revenue per share (ttm)0.81
Quarterly revenue growth (yoy)53.00%
Gross profit (ttm)N/A
EBITDA 17.03M
Net income avi to common (ttm)6.22M
Diluted EPS (ttm)0.0500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.13M
Total cash per share (mrq)0.04
Total debt (mrq)49.45M
Total debt/equity (mrq)62.33%
Current ratio (mrq)0.97
Book value per share (mrq)0.88

Cash flow statement

Operating cash flow (ttm)8.06M
Levered free cash flow (ttm)-11.14M